首頁 > 市場調查報告書 > 製藥

眼科藥物

乾眼症治療市場規模、佔有率和成長分析（按類型、藥物、產品類型、劑型、銷售管道和地區分類）－產業預測（2026-2033年）

市場調查報告書

商品編碼

1907526

乾眼症治療市場規模、佔有率和成長分析（按類型、藥物、產品類型、劑型、銷售管道和地區分類）－產業預測（2026-2033年）

Dry Eye Syndrome Treatment Market Size, Share, and Growth Analysis, By Type, By Drugs, By Product, By Dosage Form, By Sales Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球乾眼症治療市場規模預計在 2024 年達到 75.6 億美元，從 2025 年的 80.9 億美元成長到 2033 年的 139 億美元，在預測期（2026-2033 年）內複合年成長率為 7%。

由於乾眼症盛行率不斷上升以及人口老化，全球乾眼症治療市場正經歷顯著成長。人們對該疾病的認知不斷提高、診斷技術的進步以及對提升患者舒適度的重視是推動市場擴張的關鍵因素。主要治療方法包括人工淚液、抗發炎藥物和免疫調節劑等藥物。此外，再生醫學和基因療法等創新治療方法也日益受到關注，這些療法旨在解決乾眼症的根本原因。持續的研發投入可望進一步提高治療效果，並維持市場的上升趨勢。

推動全球乾眼症治療市場發展的因素

全球乾眼症治療市場受到各人群乾眼症發生率上升的顯著影響。這一成長可歸因於多種因素，包括數位化生活方式導致螢幕使用時間增加、人口老化、環境污染以及生活習慣的改變。這導致人們對有效且創新的治療方法（例如人工淚液、抗發炎藥物和淚小管栓塞）的需求增加，從而推動了市場的發展和成長。這一趨勢表明，迫切需要全面的解決方案來應對乾眼症帶來的挑戰。

全球乾眼症治療市場面臨的限制因素

全球乾眼症治療市場面臨的一大挑戰是缺乏通用的治療方案。此疾病病因複雜，由多種潛在因素引起，包括淚液分泌不足和蒸發功能障礙，導致不同患者的治療效果差異顯著。因此，患者往往需要經歷漫長的試驗誤過程才能找到緩解症狀的方法，這無疑令人沮喪。此外，乾眼症的多樣性也增加了製藥公司開發新治療方法的難度，最終阻礙了市場的成長潛力，因為必須滿足每位患者的獨特需求。

乾眼症治療市場的全球趨勢

由於消費者對傳統治療方法中防腐劑的有害影響日益關注，全球乾眼症治療市場正顯著轉向不含防腐劑的眼藥水和人工淚液。這一趨勢反映出消費者對更安全、耐受性更好的治療方案的普遍需求，從而提高了患者的依從性和滿意度。此外，配方技術的進步和創新產品的日益普及也進一步推動了這項需求。隨著生活方式的改變和環境因素導致乾眼症盛行率上升，隨著患者對有效且舒適的治療方法方案的需求不斷成長，預計該市場將實現顯著成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Novartis AG（Switzerland）
AbbVie Inc.（USA）
Sun Pharmaceutical Industries Ltd.（India）
Santen Pharmaceutical Co. Ltd.（Japan）
AFT Pharmaceuticals（New Zealand）
Johnson & Johnson Services, Inc.（USA）
Otsuka Pharmaceutical Co. Ltd.（Japan）
OASIS Medical（USA）
Bausch Health Companies Inc.（Canada）
Alcon Inc.（Switzerland）
Akorn Operating Company LLC（USA）
Alimera Sciences（USA）
GlaxoSmithKline plc（UK）
Nicox SA（France）
Novaliq GmbH（Germany）
Horus Pharma（France）
Mitotech（Russia）
Prestige Consumer Healthcare（USA）
Sentiss Pharma Pvt. Ltd.（India）
VISUfarma（Netherlands）

結論與建議

簡介目錄

Product Code: SQMIG35D2131

Global Dry Eye Syndrome Treatment Market size was valued at USD 7.56 Billion in 2024 and is poised to grow from USD 8.09 Billion in 2025 to USD 13.9 Billion by 2033, growing at a CAGR of 7% during the forecast period (2026-2033).

The global dry eye syndrome treatment market is experiencing substantial growth, driven by an increase in the prevalence of dry eye disease and an aging demographic. Heightened awareness of the condition, advancements in diagnostic technology, and an emphasis on enhancing patient comfort are pivotal factors fueling this market expansion. Key treatment modalities include pharmaceutical solutions such as artificial tears, anti-inflammatory agents, and immunomodulators. Furthermore, there is a notable shift towards innovative therapies, including regenerative medicine and gene therapy, which aim to tackle the root causes of dry eye syndrome. Continuous research and development initiatives are anticipated to further refine treatment efficacy, ensuring that the market maintains its upward momentum.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dry Eye Syndrome Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dry Eye Syndrome Treatment Market Segments Analysis

Global Dry Eye Syndrome Treatment Market is segmented by Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel and region. Based on Type, the market is segmented into Evaporative Dry Eye Syndrome and Aqueous Deficient Dry Eye Syndrome. Based on Drugs, the market is segmented into Xiidra, Restasis, Cequa, Tyrvaya, Eysuvis and Others. Based on Product, the market is segmented into Artificial Tears, Cyclosporine, Topical Corticosteroids, Punctal Plugs, Oral Omega Supplements and Others. Based on Dosage Form, the market is segmented into Eye Drops/ Solutions, Ointments and Gels, Capsules & Tablets (For Supplements) and Other Dosage Forms. Based on Sales Channel, the market is segmented into Prescription, OTC and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dry Eye Syndrome Treatment Market

The global dry eye syndrome treatment market is significantly influenced by the rising incidence of dry eye syndrome, which is increasingly prevalent across various populations. This surge can be attributed to several factors, including the rise in screen time associated with digital lifestyles, an aging demographic, environmental pollutants, and shifts in lifestyle habits. Consequently, there is a heightened demand for a range of effective and novel therapeutic options, such as artificial tears, anti-inflammatory drugs, and punctal plugs, all of which are driving advancements and growth in the market. This trend suggests a robust need for comprehensive solutions to address the challenges posed by dry eye syndrome.

Restraints in the Global Dry Eye Syndrome Treatment Market

A significant challenge for the global dry eye syndrome treatment market is the absence of a universal treatment solution. This condition is multifaceted, stemming from various underlying factors such as aqueous deficiency and evaporative dysfunction, leading to considerable variability in treatment effectiveness among patients. As a result, individuals often undergo extended periods of trial and error to find relief, which can be a frustrating experience. Additionally, the heterogeneous nature of dry eye syndrome complicates the development of new therapies by pharmaceutical companies, as they must address the distinct needs of each patient, ultimately hindering the market's growth potential.

Market Trends of the Global Dry Eye Syndrome Treatment Market

The Global Dry Eye Syndrome Treatment market is witnessing a notable shift towards preservative-free eye drops and artificial tears, driven by heightened consumer awareness regarding the adverse effects of preservatives in conventional treatments. This trend reflects a broader inclination towards safer, more tolerable therapeutic options, enhancing patient compliance and satisfaction. Additionally, advancements in formulation technologies and increasing availability of innovative products are further fueling this demand. As lifestyle changes and environmental factors contribute to the prevalence of dry eye syndrome, the market is poised for significant growth, responding to the evolving needs of patients seeking effective and comfortable solutions for their condition.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis
Trade Analysis

Global Dry Eye Syndrome Treatment Market Size by Type & CAGR (2026-2033)

Market Overview
Evaporative Dry Eye Syndrome
Aqueous Deficient Dry Eye Syndrome

Global Dry Eye Syndrome Treatment Market Size by Drugs & CAGR (2026-2033)

Market Overview
Xiidra
Restasis
Cequa
Tyrvaya
Eysuvis
Others

Global Dry Eye Syndrome Treatment Market Size by Product & CAGR (2026-2033)

Market Overview
Artificial Tears
Cyclosporine
Topical Corticosteroids
Punctal Plugs
- Removable
- Dissolvable
Oral Omega Supplements
Others

Global Dry Eye Syndrome Treatment Market Size by Dosage Form & CAGR (2026-2033)

Market Overview
Eye Drops/ Solutions
Ointments and Gels
Capsules & Tablets (For Supplements)
Other Dosage Forms

Global Dry Eye Syndrome Treatment Market Size by Sales Channel & CAGR (2026-2033)

Market Overview
Prescription
OTC
Others

Global Dry Eye Syndrome Treatment Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Global Dry Eye Syndrome Treatment Market Size & CAGR (2026-2033)

North America (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
- US
- Canada
Europe (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Santen Pharmaceutical Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AFT Pharmaceuticals (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Otsuka Pharmaceutical Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OASIS Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch Health Companies Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Inc. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Akorn Operating Company LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alimera Sciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nicox S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novaliq GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horus Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mitotech (Russia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prestige Consumer Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sentiss Pharma Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VISUfarma (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments